🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Biologic specimens

Found 0 matching trials

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

PHASE2

This phase II trial evaluates whether early switching from modified fluorou...

Status

Active Not Recruiting

Location

OHSU Knight Cancer Institute

Start Date

2021-05-27

Trial ID

NCT04539808

Treatments Being Tested

Capecitabine Fluorouracil Irinotecan Hydrochloride Leucovorin Calcium Losartan Potassium Oxaliplatin Radiation Therapy Resection Diagnostic Imaging Biospecimen Collection Gemcitabine Nab paclitaxel

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

PHASE2

This phase II trial tests how well giving dasatinib and quercetin with cycl...

Status

Recruiting

Location

Mayo Clinic in Rochester

Start Date

2025-09-18

Trial ID

NCT06940297

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Bone Marrow Aspiration Bone Marrow Biopsy Ciltacabtagene Autoleucel Computed Tomography Cyclophosphamide Dasatinib Fludarabine Positron Emission Tomography Quercetin

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

PHASE1

This phase I trial studies the side effects and best dose of autologous CD8...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2023-12-15

Trial ID

NCT06043713

Treatments Being Tested

Bendamustine Biopsy Biospecimen Collection Computed Tomography Cyclophosphamide Echocardiography Fludarabine Leukapheresis Magnetic Resonance Imaging Multigated Acquisition Scan Positron Emission Tomography T-cell Receptor-engineered T-cells

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

PHASE1

This phase I/II trial studies the side effects and best dose of ABBV-383 an...

Status

Not Yet Recruiting

Location

Mayo Clinic in Rochester

Start Date

2026-10-25

Trial ID

NCT07420959

Treatments Being Tested

Biospecimen Collection Bone Marrow Aspiration Bone Marrow Biopsy Computed Tomography Etentamig Positron Emission Tomography Questionnaire Administration

Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection

N/A

Late 2013, the first indigenous cases of chikungunya have been observed in ...

Status

Completed

Location

CHU de Guadeloupe

Start Date

2015-02

Trial ID

NCT02553369

Treatments Being Tested

Biological sample collection

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

N/A

To prospectively collect blood and tumor tissue from esophageal cancer pati...

Status

Terminated

Location

Mayo Clinic in Rochester

Start Date

2017-10-01

Trial ID

NCT03108885

Treatments Being Tested

Blood and Tissue Collection

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

PHASE3

This phase III trial compares the effect of adding cabozantinib to avelumab...

Status

Active Not Recruiting

Location

Mayo Clinic Hospital in Arizona

Start Date

2022-06-03

Trial ID

NCT05092958

Treatments Being Tested

Avelumab Biospecimen Collection Bone Scan Cabozantinib S-malate Computed Tomography Magnetic Resonance Imaging Quality-of-Life Assessment Questionnaire Administration

Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

PHASE2

This phase II/III trial compares the effect of the combination treatment wi...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2023-03-30

Trial ID

NCT05432791

Treatments Being Tested

Biospecimen Collection Bone Scan Computed Tomography Magnetic Resonance Imaging Multigated Acquisition Scan Olaparib Pazopanib Temozolomide Trabectedin Transthoracic Echocardiography Test

Tissue Procurement for Biomedical Research

N/A

The need to obtain human tissue for methods development and disease correla...

Status

Recruiting

Location

National Institute of Aging, Clinical Research Unit

Start Date

2003-06-26

Trial ID

NCT00182858

Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

French prospective multicenter, open-label study involving newly diagnosed ...

Status

Recruiting

Location

CHU Annecy-Genevois

Start Date

2023-11-17

Trial ID

NCT06130787

Treatments Being Tested

Blood and bone marrow sample

Previous Next